Papulonecrotic tuberculid.
Palaniappan V, Sadhasivamohan A, Karthikeyan K.
Clin Exp Dermatol. 2022 Oct;47(10):1820-1828. doi: 10.1111/ced.15302. Epub 2022 Aug 3.
Tuberculosis treatment-related lichenoid drug eruptions.
Katran ZY, Bulut I, Babalık A.
Int J Mycobacteriol. 2022 Oct-Dec;11(4):469-471. doi: 10.4103/ijmy.ijmy_151_22.
Drug hypersensitivity in drug-resistant tuberculosis.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D.
World Allergy Organ J. 2023 May 20;16(5):100778. doi: 10.1016/j.waojou.2023.100778. eCollection 2023 May.
Tuberculosis of the oral cavity: an uncommon but still a live issue.
Krawiecka E, Szponar E.
Postepy Dermatol Alergol. 2015 Aug;32(4):302-6. doi: 10.5114/pdia.2014.43284. Epub 2015 Aug 12.
Recurrent Genital Ulcers.
Bhanja DB, Sil A, Panigrahi A, Biswas SK.
Urology. 2021 Jan;147:33-34. doi: 10.1016/j.urology.2020.10.019. Epub 2020 Oct 24.
Management of adverse reactions to first-line tuberculosis antibiotics.
Nagarajan S, Whitaker P.
Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):333-341. doi: 10.1097/ACI.0000000000000462.
Skin tuberculosis in children: learning from India.
Sethuraman G, Ramesh V, Ramam M, Sharma VK.
Dermatol Clin. 2008 Apr;26(2):285-94, vii. doi: 10.1016/j.det.2007.11.006.
Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.
Lehloenya RJ, Dheda K.
Expert Rev Anti Infect Ther. 2012 Apr;10(4):475-86. doi: 10.1586/eri.12.13.
Lichen scrofulosorum: importance of early recognition.
Molpariya A, Ramesh V.
Clin Exp Dermatol. 2017 Jun;42(4):369-373. doi: 10.1111/ced.13050. Epub 2017 Mar 4.
Thalidomide-induced granuloma annulare.
Ferreli C, Atzori L, Manunza F, Pau M, Caddori A.
G Ital Dermatol Venereol. 2014 Jun;149(3):329-33.
